Literature DB >> 1392225

Adverse effects of antidepressants in the elderly.

L Nolan1, K O'Malley.   

Abstract

Depression is a common problem in old age and the use of antidepressant drugs is particularly prevalent among elderly patients. Limited data suggest that dose requirements may be lower in the elderly because of age-related changes in pharmacokinetics and perhaps also in sensitivity. The side effect profiles of the various antidepressants are reviewed with regard to their potential to cause specific problems in the older patients. Anticholinergic actions, orthostatic hypotension and sedative effects warrant particular care in the elderly.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1392225     DOI: 10.2165/00002512-199202050-00008

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


  61 in total

1.  Age as a factor affecting lithium therapy.

Authors:  D S Hewick; P Newbury; S Hopwood; G Naylor; J Moody
Journal:  Br J Clin Pharmacol       Date:  1977-04       Impact factor: 4.335

2.  Variability in the elimination of mianserin in elderly patients.

Authors:  E J Begg; J R Sharman; J E Kidd; R Sainsbury; D W Clark
Journal:  Br J Clin Pharmacol       Date:  1989-04       Impact factor: 4.335

Review 3.  Prescribing for the elderly. Part I: Sensitivity of the elderly to adverse drug reactions.

Authors:  L Nolan; K O'Malley
Journal:  J Am Geriatr Soc       Date:  1988-02       Impact factor: 5.562

4.  Clinical depression of the central nervous system due to diazepam and chlordiazepoxide in relation to cigarette smoking and age.

Authors: 
Journal:  N Engl J Med       Date:  1973-02-08       Impact factor: 91.245

Review 5.  Treatment-resistant depression in the elderly.

Authors:  D C Goff; M A Jenike
Journal:  J Am Geriatr Soc       Date:  1986-01       Impact factor: 5.562

6.  The giving and taking of psychotropic drugs in New Zealand.

Authors:  J Reinken; M Sparrow; A J Campbell
Journal:  N Z Med J       Date:  1982-07-28

7.  Relation of sex and aging to monoamine oxidase activity of human brain, plasma, and platelets.

Authors:  D S Robinson; J M Davis; A Nies; C L Ravaris; D Sylwester
Journal:  Arch Gen Psychiatry       Date:  1971-06

Review 8.  Prescribing for the elderly: Part II. Prescribing patterns: differences due to age.

Authors:  L Nolan; K O'Malley
Journal:  J Am Geriatr Soc       Date:  1988-03       Impact factor: 5.562

Review 9.  Maprotiline.

Authors:  W Grüter; W Pöldinger
Journal:  Mod Probl Pharmacopsychiatry       Date:  1982

10.  Adverse reactions suggesting amoxapine-induced dopamine blockade.

Authors:  T E Steele
Journal:  Am J Psychiatry       Date:  1982-11       Impact factor: 18.112

View more
  6 in total

Review 1.  Selective serotonin reuptake inhibitors in older patients. A tolerability perspective.

Authors:  U Skerritt; R Evans; S A Montgomery
Journal:  Drugs Aging       Date:  1997-03       Impact factor: 3.923

2.  Influence of age, frailty and liver function on the pharmacokinetics of brofaromine.

Authors:  J Zeeh; L Fuchs; W Bergmann; K H Antonin; F Degel; P Bieck; D Platt
Journal:  Eur J Clin Pharmacol       Date:  1996       Impact factor: 2.953

Review 3.  Paroxetine. A review of its pharmacology, therapeutic use in depression and therapeutic potential in diabetic neuropathy.

Authors:  S M Holliday; G L Plosker
Journal:  Drugs Aging       Date:  1993 May-Jun       Impact factor: 3.923

Review 4.  Fluoxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in older patients with depressive illness.

Authors:  M G Harris; P Benfield
Journal:  Drugs Aging       Date:  1995-01       Impact factor: 3.923

Review 5.  Venlafaxine. A review of its pharmacology and therapeutic potential in depression.

Authors:  S M Holliday; P Benfield
Journal:  Drugs       Date:  1995-02       Impact factor: 9.546

6.  Impact of age and CYP2D6 genotype on exposure of zuclopenthixol in patients using long-acting injectable versus oral formulation-an observational study including 2044 patients.

Authors:  Marit Tveito; Robert Løvsletten Smith; Espen Molden; Gudrun Høiseth
Journal:  Eur J Clin Pharmacol       Date:  2020-09-30       Impact factor: 2.953

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.